Today the Administration took a historic step to direct additional resources to help address the staggering human and economic toll created by the epidemic of opioid addiction. We thank President Trump for his leadership in further empowering public and private parties…
Erytech Unveils New Data for Pancreatic Cancer Combination Therapy
A French biotech firm testing a unique treatment approach for metastatic pancreatic cancer reported promising mid-stage results for its lead candidate. Erytech Pharma evaluated eryaspase (Graspa), an enzyme called L-asparaginase encapsulated in red blood cells, in combination with chemotherapy as a…
Zika Virus Kills Brain Cancer Stem Cells
While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine in St. Louis and the…
Study: Asthma Medicine Halves Parkinson’s Risk
Parkinson’s disease is a chronic disease of unknown cause. The patients destroy the cells in the brain that help control movement. Typical symptoms are tremors, stiffness in the arms and legs, and poor coordination. This limits the ability to participate in everyday…
Anti-Inflammatory Drug Reduces Heart Attack, Cancer Risk
About 25 percent of heart attack patients will experience another cardiovascular event within five years, even if they do not have high cholesterol heart attack recurrence is present. Researchers at Brigham and Women’s hospital in Boston have shown that lowering inflammation,…
5 ways to boost Minorities’ Participation in Clinical Trials
Minorities’ participation in clinical trials is often an issue of debate among the clinical research industry. Anyway, most of us agree that their participation is crucial in order to develop better treatments for everybody. That’s why as part of the professionals…
Drug Trial Shows Promise for Deadly Neurological Disorder
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20. The disease, called Niemann-Pick type C (NPC), causes cholesterol to build up in neurons, leading to a…
CLINICAL TRIALS STARTUP PHASE: Methods Used to Identify Clinical Sites
Clinical Trial Startup Phase: How to Identify Clinical Sites Managing Clinical Studies is a challenging job and traditionally professionals use a numerous amount of tools in the startup process including, phone, fax, email and Excel spreadsheets. The Clinical Trial startup process includes…
Hispanics and Diabetes Clinical Studies
Hispanics and Diabetes People with Hispanic or Latino backgrounds are at higher risk for developing type 2 diabetes than non-Hispanic Caucasians. This is a fact that researchers have long known. However, most research has looked at this group as a whole,…